Description
AYURVEDIC SUPPLEMENT
INDICATION
chronic bronchitis and chronic asthma.
DOSAGE
10 – 15 ml, with twice the amount of boiled and cooled water once or two
times a day before food.
Sale!
ELAKANADI KASHAYAM
$20.00 $17.99
AYURVEDIC SUPPLEMENT
INDICATION
chronic bronchitis and chronic asthma.
DOSAGE
10 – 15 ml, with twice the amount of boiled and cooled water once or two
times a day before food.
RelatedProducts
ASOKARISHTAM
Ayurvedic herbal supplement
MENSTRO-REGULATORY TONIC
INDICATION
Useful in Painful menstruation, heavy periods, fever, bleeding disorders such
as nasal bleeding, bleeding hemorrhoids, inflammation, indigestion and lack
of taste.
DOSAGE:
12 – 24 ml. one or two times a day, usually advised after food.
If needed, equal quantity of water can be added before consumption.
KANAKASAVAM
Ayurvedic herbal supplement
ANTI ASTHMATIC TONIC
INDICATION
Widely used in the treatment of respiratory conditions such as Asthma,
cough, fever and bleeding diseases. It is a natural mucolytic and bronchodilator.
It is also in bleeding diseases, injuries and chronic fever. It helps to
relieve chest mucous congestion.
DOSAGE:
12 – 24 ml. one or two times a day, usually advised after food.
If needed, equal quantity of water can be added before consumption.
VETTUMARAN GULIKA TABLET
ANTIPYRECTIC AYURVEDIC SUPPLEMENT
INDICATION
fever, vomiting, abdominal colic pain
DOSAGE
1 tablet two times a day or as directed by Ayurvedic physician
Swasanandam Gulika tablet
Antiasthmatic Supplement
INDICATION
Bronchitis,Asthma,cough and cold
DOSAGE
125 mg) 1 – 2 tablets, once or twice a day, after food or as directed by
Ayurvedic Physician
BALARISHTAM
Ayurvedic herbal supplement
VATA ALLEVIATING TONIC
INDICATION
Useful in neuralgia, hemiplegia, paraplegia, arthritis, spondylosis etc. It is
also a very good nervine tonic. It improves strength of nerves, muscles and
bones.
DOSAGE:
12 – 24 ml. one or two times a day, usually advised after food.
If needed, equal quantity of water can be added before consumption.
Reviews
There are no reviews yet.